Industry News/HAV

FDA Approves Hepatitis A Virus Vaccine

Published in Blood Weekly, March 6th, 1995

SmithKline Beecham, Philadelphia, Pennsylvania, announced that the U.S. Food and Drug Administration (FDA) has licensed SmithKline Beecham Biologicals to market Havrix (Hepatitis A Vaccine, Inactivated), the world's first hepatitis A vaccine.

The vaccine is indicated for active immunization in people at risk of exposure to hepatitis A virus, including travelers to Mexico, parts of the Caribbean, South and Central America, Africa, Asia (except Japan), the Mediterranean basin, Eastern Europe and the Middle East. Havrix, manufactured by SmithKline Beecham Biologicals and distributed by SmithKline Beecham Pharmaceuticals, provides protection against hepatitis A.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1995-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry